Imagine that at a routine medical check-up your doctor takes a urine sample, then reports a few days later that your risk of type 2 diabetes is normal, but there are hints that your arteries are furring up. A similar scenario has been promised for the past 20 years by those working in genomics and proteomics, but has not yet materialized. Now, however, an increasing number of researchers are claiming that metabolomics — the study of all the body's metabolites — will finally come up with the goods.
展开▼
